Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001–2016

[Figure: see text] BACKGROUND: Most countries use 3-dose pneumococcal conjugate vaccine (PCV) schedules; a 4-dose (3 primary and 1 booster) schedule is licensed for US infants. We evaluated the invasive pneumococcal disease (IPD) breakthrough infection incidence in children receiving 2 vs 3 primary...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pediatrics
Main Authors: Adebanjo, Tolulope A., Pondo, Tracy, Yankey, David, Hill, Holly A., Gierke, Ryan, Apostol, Mirasol, Barnes, Meghan, Petit, Susan, Farley, Monica, Harrison, Lee H., Holtzman, Corinne, Baumbach, Joan, Bennett, Nancy, McGuire, Suzanne, Thomas, Ann, Schaffner, William, Beall, Bernard, Whitney, Cynthia G., Pilishvili, Tamara
Format: Artigo
Jezik:Inglês
Izdano: American Academy of Pediatrics 2020
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055927/
https://ncbi.nlm.nih.gov/pubmed/32054822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2019-0836
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki